Erythromycin Tablet, Film Coated
Product Images NDC 73082-020

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 73082-020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Orange Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cont-label-250mg-100-tab.jpg (Cont Label 250mg 100 Tab)

FDA Label Image

Cont-label-250mg-30-tab.jpg (Cont Label 250mg 30 Tab)

Cont-label-250mg-30-tab.jpg (Cont Label 250mg 30 Tab)
LSBT and Erythromycin Tablets, USP are mentioned. However, the rest of the text is not readable.*
FDA Label Image

Cont-label-500mg-100-tab.jpg (Cont Label 500mg 100 Tab)

Cont-label-500mg-100-tab.jpg (Cont Label 500mg 100 Tab)
This is a product label for Erythromycin Tablets, USP with NDC number 73082-020-01. The tablets are orange and round with text "TR BT e et" and "E@ID" imprinted. They are available only by prescription.*
FDA Label Image

Cont-label-500mg-30-tab.jpg (Cont Label 500mg 30 Tab)

Cont-label-500mg-30-tab.jpg (Cont Label 500mg 30 Tab)
Description not available.*
FDA Label Image

Erythro-structure (Erythro Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.